'New Directions in Immuno-Oncology - Emerging biology for therapy and stratification' is an international cancer immunology conference taking place on 10-12 September in London.
The conference is supported by King’s Health Partners and Birmingham Cancer Research UK Centres (CRUK), and the Experimental Cancer Medicine Centres (ECMC).
The conference aims to bring together a broad cross-section of the community of researchers and clinicians working at the cutting edge of immune-oncology interventions and their stratified application. It will cover both the immediate and longer-term prospects in the development pipeline and the means through which we might better determine effective deployment of these interventions, including technology platforms and the ‘big data’ analytical hurdles.
Abstract submission deadline: 1st July 2019.